Article info

Download PDFPDF

Short report
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

Authors

  1. Correspondence to James Welsh, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; JWelsh{at}mdanderson.org
View Full Text

Citation

Chen D, Menon H, Verma V, et al
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

Publication history

  • Accepted December 31, 2019
  • First published January 28, 2020.
Online issue publication 
January 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.